Video Library

Inside Parkwalk: The Spinout Ecosystem

Inside Parkwalk: The Spinout Ecosystem

Inside Parkwalk: Deal Sourcing

Inside Parkwalk: Deal Sourcing

Inside Parkwalk: Expertise and Track Record

Inside Parkwalk: Expertise and Track Record
Marley Health is building an AI-powered pet healthcare platform designed to help veterinarians and pet owners spot health issues earlier. Hear from CEO & Co-Founder Nate Notwell.
Paragraf CEO and Co-Founder Simon Thomas discusses Paragraf's founding and the latest progress in bringing graphene-based electronics into commercial production.
Brainomix CEO Michalis Papadakis explains how its technology is helping clinicians make faster, more accurate decisions, improving outcomes for patients worldwide.
A look at the experience behind Parkwalk’s investment team - showcasing the depth, discipline and specialist expertise that power our track record.
Discover how Parkwalk identifies groundbreaking innovation early, tapping into the UK’s leading universities to uncover standout commercial opportunities.
A breakdown of the UK spinout landscape - where ideas begin, how founders grow, and the ecosystem Parkwalk helps to accelerate.
An introduction to Parkwalk’s Northern Universities Venture Fund, in conjunction with Northern Gritstone, backing university spinouts across the Northern Arc.

No video found
A highlight reel of groundbreaking technologies, ambitious teams and standout milestones from across the Parkwalk portfolio.
A snapshot of Parkwalk’s evolution, from early beginnings to becoming the UK’s most active investor in university spinouts.
An overview of cutting‑edge breakthroughs transforming healthcare, and why Parkwalk backs the innovators reshaping patient outcomes.
Meet the founders redefining what’s possible in AI and advanced hardware - pioneering technologies built for global impact.
An introduction to the companies driving sustainability, precision agriculture and next‑gen environmental sensing.

The products shown on this website will place your capital at risk and investors may not get back the full amount invested. Past performance may not be repeated and is not indicative of future results.

Parkwalk funds invest in smaller and unquoted companies which carry a higher risk than many other forms of investment. There is no guarantee that target returns will be achieved. There is no liquid market for shares in unquoted companies and there can be difficulties, in valuing and disposing of investments in such companies. Tax reliefs will depend on the investors’ individual circumstance and are subject to change.

Parkwalk does not provide investment or tax advice, and the information on this website should not be construed as such. Parkwalk recommends investors seek advice from a regulated financial adviser that specialises in EIS fund investments before making an investment decision. An investment into any of the funds managed by Parkwalk may only be made on the basis of the information set out in the Information Memorandum and Key Information Document.

The information on this website is directed at United Kingdom residents only. Please confirm you have read this warning and are happy to proceed.